Abstract:Background Altered expression of astrocyte elevated gene-1 (AEG-1) is associated with tumorigenesis and progression. The present study aimed to investigate the clinical and prognostic significance of AEG-1 expression in pancreatic ductal adenocarcinoma (PDAC). Methods Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blot analyses were employed to assess AEG-1 expression in three pancreatic cancer cell lines and normal pancreatic duct epithelial cells. qRT-PCR and immunohistochemical analyses were performed to detect AEG-1 expression in ten pairs of PDAC and normal pancreas tissues. Immunohistochemistry was then used to examine AEG-1 expression in paraffin-embedded tissues obtained from 105 patients, and its association with clinicopathological parameters including cancer classification was examined. Kaplan-Meier analysis was performed to study the survival rates of patients. Results Expression of AEG-1 mRNA and protein was markedly higher in pancreatic cancer cell lines than that in the normal pancreatic duct epithelial cells. AEG-1 expression was evidently upregulated in PDAC tissues compared to that of the matched distant normal pancreas tissues. qRT-PCR data revealed that the tumor/non-tumor ratio of AEG-1 expression was >1.5-fold (up to 6.5-fold). Immunohistochemical data showed that AEG-1 protein was detected in 98.09% (103/105) of PDAC tissues; and they were found to be associated with tumor size ( P = 0.025), advanced clinical stage ( P = 0.004), T classification ( P = 0.006), N classification ( P = 0.003), and M classification ( P = 0.007). Furthermore, Kaplan-Meier analysis showed that patients with high AEG-1-expressed PDAC had shorter overall survival. A multivariate Cox regression analysis revealed that clinical stage, T classification, and AEG-1 expression were the independent prognostic predictors for PDAC. Conclusions This study suggests that AEG-1 protein was highly expressed in PDAC and associated with poor prognosis of the patients.

[The Expression of Plasminogen Activator Inhibitor-1 (PAI-1) Gene in Human Astrocytomas].

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

Expression of Enos and VEGF in Association with Angiogenesis of Human Astrocytoma

Polymeric Immunoglobulin Receptor Expression is Predictive of Poor Prognosis in Glioma Patients.

Expression and Significance of Matrix Matalloproteinase and Tissue Inhibitor of Metalloproteinase in Human Astrocytomas

Polymeric Immunoglobulin Receptor Expression Is Predictive Of Poor Prognosis In Glioma Patients

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

[Inhibitor of Plasminogen Activator 1 (PAI-1) in Hepatocellular Carcinoma].

Apoptosis in Supratentorial Astrocytomas and Expression of Apoptosis Related Gene P53 and Bcl-2

Apoptosis and Proliferation Markers in Diffusely Infiltrating Astrocytomas: Profiling of 17 Molecules.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Protein Microarrays for Quantitative Detection of Pai-1 in Serum

Plasminogen activator inhibitor-1 mRNA is localized in the ciliary epithelium of the rodent eye

Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors

Low Expression of PAI-2 As a Novel Marker of Portal Vein Tumor Thrombosis and Poor Prognosis in Hepatocellular Carcinoma.

Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1

High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas

Expression and Significance of Plasminogen Activator Inhibitor in Osteoarthritis Synovial Membrane

Over-expression of ?-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Expressions of vascular endothelial growth factor gene protein in astrocytoma and its clinical significance